Biogen to buy the retinal gene therapy maker Nightstar
Tuesday, March 5, 2019 - 03:51
in Mathematics & Economics
The $800 million purchase is the third gene therapy acquisition announced in a week
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via